Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

A systematic review and quality assessment of individualised breast cancer risk prediction models

  • Louro, Javier|||0000-0002-2985-3301
  • Posso, Margarita|||0000-0002-5053-257X
  • Hilton Boon, Michele|||0000-0002-2240-7923
  • Román, Marta|||0000-0001-9076-8918
  • Domingo, Laia|||0000-0003-4420-0891
  • Castells, Xavier|||0000-0002-2528-0382
  • Sala, Maria|||0000-0002-9955-8746
Individualised breast cancer risk prediction models may be key for planning risk-based screening approaches. Our aim was to conduct a systematic review and quality assessment of these models addressed to women in the general population. We followed the Cochrane Collaboration methods searching in Medline, EMBASE and The Cochrane Library databases up to February 2018. We included studies reporting a model to estimate the individualised risk of breast cancer in women in the general population. Study quality was assessed by two independent reviewers. Results are narratively summarised. We included 24 studies out of the 2976 citations initially retrieved. Twenty studies were based on four models, the Breast Cancer Risk Assessment Tool (BCRAT), the Breast Cancer Surveillance Consortium (BCSC), the Rosner & Colditz model, and the International Breast Cancer Intervention Study (IBIS), whereas four studies addressed other original models. Four of the studies included genetic information. The quality of the studies was moderate with some limitations in the discriminative power and data inputs. A maximum AUROC value of 0.71 was reported in the study conducted in a screening context. Individualised risk prediction models are promising tools for implementing risk-based screening policies. However, it is a challenge to recommend any of them since they need further improvement in their quality and discriminatory capacity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differences in breast cancer risk after benign breast disease by type of screening diagnosis

  • Louro, Javier|||0000-0002-2985-3301
  • Román, Marta|||0000-0001-9076-8918
  • Posso, Margarita|||0000-0002-5053-257X
  • Comerma, Laura|||0000-0002-0249-4636
  • Vidal, Carmen|||0000-0003-2768-2710
  • Saladié, Francina|||0000-0002-1783-4066
  • Alcántara Souza, Rodrigo|||0000-0003-4365-5640
  • Sánchez Movellán, Mar
  • Quintana Ruiz, Maria Jesús|||0000-0002-1055-9786
  • del Riego, Javier|||0000-0001-9200-3505
  • Ferrer, Joana
  • Peñalva, Lupe
  • Bargalló, Xavier
  • Prieto, Miguel
  • Sala, Maria|||0000-0002-9955-8746
  • Castells, Xavier|||0000-0002-2528-0382
We aimed to assess differences in breast cancer risk across benign breast disease diagnosed at prevalent or incident screens. We conducted a retrospective cohort study with data from 629,087 women participating in a long-standing population-based breast cancer screening program in Spain. Each benign breast disease was classified as non-proliferative, proliferative without atypia, or proliferative with atypia, and whether it was diagnosed in a prevalent or incident screen. We used partly conditional Cox hazard regression to estimate the adjusted hazard ratios of the risk of breast cancer. Compared with women without benign breast disease, the risk of breast cancer was significantly higher (p-value = 0.005) in women with benign breast disease diagnosed in an incident screen (aHR, 2.67; 95%CI: 2.24-3.19) than in those with benign breast disease diagnosed in a prevalent screen (aHR, 1.87; 95%CI: 1.57-2.24). The highest risk was found in women with a proliferative benign breast disease with atypia (aHR, 4.35; 95%CI: 2.09-9.08, and 3.35; 95%CI: 1.51-7.40 for those diagnosed at incident and prevalent screens, respectively), while the lowest was found in women with non-proliferative benign breast disease (aHR, 2.39; 95%CI: 1.95-2.93, and 1.63; 95%CI: 1.32-2.02 for those diagnosed at incident and prevalent screens, respectively). Our study showed that the risk of breast cancer conferred by a benign breast disease differed according to type of screen (prevalent or incident). To our knowledge, this is the first study to analyse the impact of the screening type on benign breast disease prognosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening

  • Louro, Javier|||0000-0002-2985-3301
  • Román, Marta|||0000-0001-9076-8918
  • Posso, Margarita|||0000-0002-5053-257X
  • Vázquez, Ivonne|||0000-0002-5305-1560
  • Saladié, Francina|||0000-0002-1783-4066
  • Rodríguez Arana, Ana|||0000-0003-3115-0178
  • Quintana Ruiz, Maria Jesús|||0000-0002-1055-9786
  • Domingo, Laia|||0000-0003-4420-0891
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Vernet-Tomas, Maria|||0000-0002-5575-2475
  • Sala, Maria|||0000-0002-9955-8746
  • Castells, Xavier|||0000-0002-2528-0382
Several studies have proposed personalized strategies based on women's individual breast cancer risk to improve the effectiveness of breast cancer screening. We designed and internally validated an individualized risk prediction model for women eligible for mammography screening. Retrospective cohort study of 121,969 women aged 50 to 69 years, screened at the long-standing population-based screening program in Spain between 1995 and 2015 and followed up until 2017. We used partly conditional Cox proportional hazards regression to estimate the adjusted hazard ratios (aHR) and individual risks for age, family history of breast cancer, previous benign breast disease, and previous mammographic features. We internally validated our model with the expected-to-observed ratio and the area under the receiver operating characteristic curve. During a mean follow-up of 7.5 years, 2,058 women were diagnosed with breast cancer. All three risk factors were strongly associated with breast cancer risk, with the highest risk being found among women with family history of breast cancer (aHR: 1.67), a proliferative benign breast disease (aHR: 3.02) and previous calcifications (aHR: 2.52). The model was well calibrated overall (expected-to-observed ratio ranging from 0.99 at 2 years to 1.02 at 20 years) but slightly overestimated the risk in women with proliferative benign breast disease. The area under the receiver operating characteristic curve ranged from 58.7% to 64.7%, depending of the time horizon selected. We developed a risk prediction model to estimate the short- and long-term risk of breast cancer in women eligible for mammography screening using information routinely reported at screening participation. The model could help to guiding individualized screening strategies aimed at improving the risk-benefit balance of mammography screening programs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography

  • Román, Marta|||0000-0001-9076-8918
  • Louro, Javier|||0000-0002-2985-3301
  • Posso, Margarita|||0000-0002-5053-257X
  • Vidal, Carmen|||0000-0003-2768-2710
  • Bargalló, Xavier
  • Vázquez, Ivonne|||0000-0002-5305-1560
  • Quintana Ruiz, Maria Jesús|||0000-0002-1055-9786
  • Alcántara Souza, Rodrigo|||0000-0003-4365-5640
  • Saladié, Francina|||0000-0002-1783-4066
  • del Riego, Javier|||0000-0001-9200-3505
  • Peñalva, Lupe
  • Sala, Maria|||0000-0002-9955-8746
  • Castells, Xavier|||0000-0002-2528-0382
Assessing the long-term risk of breast cancer after diagnosis of benign breast disease by mammography is of utmost importance to design personalised screening strategies. We analysed individual-level data from 778,306 women aged 50-69 years with at least one mammographic screening participation in any of ten breast cancer screening centers in Spain from 1996 to 2015, and followed-up until 2017. We used Poisson regression to compare the rates of incident breast cancer among women with and without benign breast disease. During a median follow-up of 7.6 years, 11,708 (1.5%) women had an incident of breast cancer and 17,827 (2.3%) had a benign breast disease. The risk of breast cancer was 1.77 times higher among women with benign breast disease than among those without (95% CI: 1.61 to 1.95). The relative risk increased to 1.99 among women followed for less than four years, and remained elevated for two decades, with relative risk 1.96 (95% CI: 1.32 to 2.92) for those followed from 12 to 20 years. Benign breast disease is a long-term risk factor for breast cancer. Women with benign breast disease could benefit from closer surveillance and personalized screening strategies.